Latest News

Altislabs’ AI tool could help drugmakers cut risk in late-stage cancer trials

Raidium joins Debiopharm Innovation Fund Portfolio

The future of secure Data Collaboration in Healthcare and AI

Genialis advances biomarker discovery to reduce risk in cancer drug development targeting DNA damage response pathways

Debiopharm Innovation Fund welcomes Hope AI to their portfolio

Tempus announces a collaboration with Genialis to develop RNA-based biomarker algorithms

Debiopharm Innovation Fund: Leading European Digital Health investor with award-winning portfolio companies

SIFTED – Blueprint for Change: How startups and a CVC are shaping the future of clinical development

BC Platforms’ European Health Data Space-ready platform to support EU’s Digital Healthcare transformation